William Meury
CIK 1536778 · Chief Executive Officer · last filed 2026-04-17
William Meury is a Chief Executive Officer who has filed 52 SEC Form 4 insider transactions across 7 companies since 2011. The most recent filing, for INCY, was dated Apr 17, 2026. Across all open-market trades the lifetime net is −$19.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $19.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$19.13M
7
52
-$19.27M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Chief Executive Officer | 161,101 | $108.53 | $17.48M | $0 | 3 | 2026-04-17 |
| SNDX | Director | 90,000 | $18.25 | $1.64M | -$1.70M | 9 | 2025-02-07 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | President and CEO | 19,037 | $329.83 | $6.28M | $0 | 4 | 2024-03-18 |
| Allergan plc (AGN) Delisted | EVP & Chief Commercial Officer | 0 | — | — | -$3.78M | 8 | 2020-05-11 |
| Allergan plc (AGNpA) Delisted | Chief Commercial Officer | 42,521 | — | — | -$11.51M | 10 | 2018-02-16 |
| Allergan plc (ACTpA) Delisted | See Remarks | 71,194 | — | — | $0 | 2 | 2015-05-19 |
| Forest Laboratories, LLC (FRX) Delisted | EVP - Sales and Marketing | 87,542 | $12.00 | $1.05M | -$2.28M | 11 | 2013-12-10 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-17 | INCY | Exer (M) | +125,000 | $0 | EDGAR |
| 2025-07-02 | INCY | Grant (A) | +36,101 | $0 | EDGAR |
| 2025-06-30 | INCY | Grant (A) | — | $0 | EDGAR |
| 2025-02-07 | SNDX | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-03-18 | Karuna Therapeutics, Inc. (KRTX) Delisted | Disp (D) | −29,379 | -$9.70M | EDGAR |
| 2024-02-15 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-09 | SNDX | Grant (A) | +17,000 | $0 | EDGAR |
| 2023-12-29 | Karuna Therapeutics, Inc. (KRTX) Delisted | Tax (F) | −8,694 | -$2.75M | EDGAR |
| 2023-08-03 | SNDX | Mixed | — | -$1.03M | EDGAR |
| 2023-02-03 | SNDX | Grant (A) | +16,000 | $0 | EDGAR |